Cargando…

UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria

Anticomplement activity played an important role in anti-inflammatory effects of traditional Chinese herbs. The total flavonoids of Sophora tonkinensis (TFST) were inactive on the complement system but showed obvious anticomplement activity after incubated with human intestinal bacteria in vitro. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xin, Lu, Yan, Chen, Shaoxin, Chen, Daofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127204/
https://www.ncbi.nlm.nih.gov/pubmed/32092632
http://dx.doi.org/10.1016/j.jpba.2020.113176
_version_ 1783516309531656192
author Jin, Xin
Lu, Yan
Chen, Shaoxin
Chen, Daofeng
author_facet Jin, Xin
Lu, Yan
Chen, Shaoxin
Chen, Daofeng
author_sort Jin, Xin
collection PubMed
description Anticomplement activity played an important role in anti-inflammatory effects of traditional Chinese herbs. The total flavonoids of Sophora tonkinensis (TFST) were inactive on the complement system but showed obvious anticomplement activity after incubated with human intestinal bacteria in vitro. In order to discover the metabolic activation of TFST by intestinal flora, the constituents of TFST and its metabolites were identified by UPLC-ESI-LTQ/MS. Their anticomplement activities were evaluated through the classical and alternative pathway. As a result, eighteen flavonoids were identified, including seven flavonoid glycosides, five aglycones and six isoprenylated flavonoids. All the glycosides (daidzein-4′-glucoside-rhamnoside, sophorabioside, rutin, isoquercitrin, quercitrin, ononin, trifolirhizin) were metabolized into their corresponding aglycones in different extent by human intestinal bacteria, resulting in the contents of the five aglycones were highly increased in 24 h. However, no changes have occurred on the six isoprenylated flavonoids. Interestingly, three aglycones (quercetin, formononetin and maackiain) had significantly more potent anticomplement activities than their prototype glycosides. The results indicated that the enhancement of TFST anticomplement activity was attributed to the active aglycones, especially formononetin and quercetin, produced by human intestinal bacteria. These aglycones are likely to be among the potential active components of S. tonkinensis for its inhibiting inflammation effects.
format Online
Article
Text
id pubmed-7127204
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71272042020-04-08 UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria Jin, Xin Lu, Yan Chen, Shaoxin Chen, Daofeng J Pharm Biomed Anal Article Anticomplement activity played an important role in anti-inflammatory effects of traditional Chinese herbs. The total flavonoids of Sophora tonkinensis (TFST) were inactive on the complement system but showed obvious anticomplement activity after incubated with human intestinal bacteria in vitro. In order to discover the metabolic activation of TFST by intestinal flora, the constituents of TFST and its metabolites were identified by UPLC-ESI-LTQ/MS. Their anticomplement activities were evaluated through the classical and alternative pathway. As a result, eighteen flavonoids were identified, including seven flavonoid glycosides, five aglycones and six isoprenylated flavonoids. All the glycosides (daidzein-4′-glucoside-rhamnoside, sophorabioside, rutin, isoquercitrin, quercitrin, ononin, trifolirhizin) were metabolized into their corresponding aglycones in different extent by human intestinal bacteria, resulting in the contents of the five aglycones were highly increased in 24 h. However, no changes have occurred on the six isoprenylated flavonoids. Interestingly, three aglycones (quercetin, formononetin and maackiain) had significantly more potent anticomplement activities than their prototype glycosides. The results indicated that the enhancement of TFST anticomplement activity was attributed to the active aglycones, especially formononetin and quercetin, produced by human intestinal bacteria. These aglycones are likely to be among the potential active components of S. tonkinensis for its inhibiting inflammation effects. Elsevier B.V. 2020-05-30 2020-02-14 /pmc/articles/PMC7127204/ /pubmed/32092632 http://dx.doi.org/10.1016/j.jpba.2020.113176 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jin, Xin
Lu, Yan
Chen, Shaoxin
Chen, Daofeng
UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria
title UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria
title_full UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria
title_fullStr UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria
title_full_unstemmed UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria
title_short UPLC-MS identification and anticomplement activity of the metabolites of Sophora tonkinensis flavonoids treated with human intestinal bacteria
title_sort uplc-ms identification and anticomplement activity of the metabolites of sophora tonkinensis flavonoids treated with human intestinal bacteria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127204/
https://www.ncbi.nlm.nih.gov/pubmed/32092632
http://dx.doi.org/10.1016/j.jpba.2020.113176
work_keys_str_mv AT jinxin uplcmsidentificationandanticomplementactivityofthemetabolitesofsophoratonkinensisflavonoidstreatedwithhumanintestinalbacteria
AT luyan uplcmsidentificationandanticomplementactivityofthemetabolitesofsophoratonkinensisflavonoidstreatedwithhumanintestinalbacteria
AT chenshaoxin uplcmsidentificationandanticomplementactivityofthemetabolitesofsophoratonkinensisflavonoidstreatedwithhumanintestinalbacteria
AT chendaofeng uplcmsidentificationandanticomplementactivityofthemetabolitesofsophoratonkinensisflavonoidstreatedwithhumanintestinalbacteria